HAL in 2001: a fat oddity. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HAL in 2001: a fat oddity.

GMHC Treat Issues. 1999 Mar;13(3):2-5, 8. Unique Identifier : AIDSLINE AIDS/20700064
Grinberg L; Torres G


Abstract: HIV-associated lipodystrophy (HAL) is a side effect of successful viral suppression using highly active antiretroviral therapy (HAART). HAL manifests itself through a variety of changes in body composition and metabolism. Changes include unusual fat redistribution throughout the body and altered mechanics of fat metabolism that can result in high levels of triglycerides and cholesterol. Some of these symptoms were apparent before protease inhibitors (PIs) became widely available, and may be associated with other factors, including different antivirals and underlying metabolism problems. However, the majority of cases appear to be linked to PI use. There is no definitive test to diagnose HAL, and prevalence rates range from 3 percent to 80 percent. Results of several studies are presented, including some involving patients with lipodystrophy who have not taken PIs. The long-term effects of hyperlipidemia are described.


Keywords: NEWSLETTER ARTICLE Body Composition Drug Therapy, Combination Female HIV Infections/*COMPLICATIONS/DRUG THERAPY/METABOLISM HIV Protease Inhibitors/*ADVERSE EFFECTS Human Hyperglycemia/ETIOLOGY Hyperlipidemia/EPIDEMIOLOGY/ETIOLOGY/PREVENTION & CONTROL Lipodystrophy/EPIDEMIOLOGY/*ETIOLOGY/PREVENTION & CONTROL Male Prevalence Triglycerides/BLOOD

KWDnewsletterarticlebodycompositiondrugtherapy,combinationfemalehivinfections/KWDcomplications/drugtherapy/metabolismhivproteaseinhibitors/KWDadverseeffectshumanhyperglycemia/etiologyhyperlipidemia/epidemiology/etiology/prevention&controllipodystrophy/epidemiology/KWDetiology/prevention&controlmaleprevalencetriglycerides/blood
000330
A0030885


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .